I am a
Home I AM A Search Login

Papers of the Week

2022 May 11

Lancet Respir Med

Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.


Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, Liu M, Wang Y, Cui D, Wang Y, Zhang X, Shang L, Zhong J, Wang X, Wang J, Cao B
Lancet Respir Med. 2022 May 11.
PMID: 35568052.


With the ongoing COVID-19 pandemic, growing evidence shows that a considerable proportion of people who have recovered from COVID-19 have long-term effects on multiple organs and systems. A few longitudinal studies have reported on the persistent health effects of COVID-19, but the follow-up was limited to 1 year after acute infection. The aim of our study was to characterise the longitudinal evolution of health outcomes in hospital survivors with different initial disease severity throughout 2 years after acute COVID-19 infection and to determine their recovery status.